Security key
449778109
IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBTQ)
CUSIP: 449778109
Q4 2022 13F Holders as of 31 Dec 2022
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 14,281,285
- Total 13F value
- $32,846,954
- Share change
- -1,054,245
- SEC-reported price per share
- $2.30
- Number of holders
- 17
- Value change
- -$2,578,155
- Number of buys
- 4
- Number of sells
- 8
- Shares outstanding
- 79,751,533
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2022
Institutions
17
Top holders
10
IOBTQ full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2023
Previous quarter: Q3 2022
IO Biotech, Inc. SEC filings
IO Biotech, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 449778109
Recent filing periods:
Ownership snapshot
Top reported holders of IOBTQ - IO Biotech, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Novo Holdings A/S
Disclosed value leader
Novo Holdings A/S
Comparable rows
15/15
Latest evidence
30 Sep 2022
13F
Lead comparable stake: 4.1%
Showing 1-6 of 15 holder rows.
Quick read
Novo Holdings A/S leads the comparable SEC ownership view at 4.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Novo Holdings A/S's linked filing trail.
Comparable ownership
Top 5
Novo Holdings A/S
4.1%
Vivo Capital, LLC
3.8%
PFM Health Sciences, LP
2.7%
Avoro Capital Advisors LLC
2.6%
RA CAPITAL MANAGEMENT, L.P.
2.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Novo Holdings A/S |
13F
Company
|
4.1%
|
$8,883,000
3,277,932 shares
|
— | 30 Sep 2022 |
| Vivo Capital, LLC |
13F
Company
|
3.8%
|
$8,172,000
3,015,545 shares
|
— | 30 Sep 2022 |
| PFM Health Sciences, LP |
13F
Company
|
2.7%
|
$5,851,000
2,159,155 shares
|
— | 30 Sep 2022 |
| Avoro Capital Advisors LLC |
13F
Company
|
2.6%
|
$5,571,000
2,055,883 shares
|
— | 30 Sep 2022 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
2.3%
|
$5,035,000
1,857,755 shares
|
— | 30 Sep 2022 |
| Capital World Investors |
13F
Company
|
1.5%
|
$3,347,000
1,235,000 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
17
Shares
14,281,285
Rows available
17
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
20
Q4 2022 holders
17
Holder diff
-3
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend